DIAsource Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 84

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 2

DIAsource General Information

Description

Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious diseases. The company's focus lies in offering a panel of accurate, reliable assays that allow the performant detection and measurement of various forms of Vitamin D metabolites, as well as developing new antibodies and assays to measure relevant biomarkers, enabling clients to detect and monitor endocrine disorders and infectious and auto-immune diseases.

Contact Information

Website
www.diasource-diagnostics.com
Formerly Known As
Biosource Europe, Medgenics
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Rue du Bosquet, 2
  • 1348 Louvain-la-Neuve
  • Belgium
+32 010
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Acquirer
BioVendor Laboratorni Medicina
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Rue du Bosquet, 2
  • 1348 Louvain-la-Neuve
  • Belgium
+32 010

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DIAsource Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DIAsource‘s full profile, request access.

Request a free trial

DIAsource Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious dis
Diagnostic Equipment
Louvain-la-Neuve, Belgium
84 As of 2024

Melbourn, United Kingdom
 

Puteaux, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DIAsource Competitors (29)

One of DIAsource’s 29 competitors is LEX Diagnostics, a Corporate Backed or Acquired company based in Melbourn, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LEX Diagnostics Corporate Backed or Acquired Melbourn, United Kingdom
ELITechGroup Formerly PE-Backed Puteaux, France
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
BioGenex Laboratories Corporation Fremont, CA
Nanomix Formerly VC-backed San Leandro, CA
You’re viewing 5 of 29 competitors. Get the full list »

DIAsource Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

DIAsource Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130084585-A1 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010
US-9322828-B2 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010
AU-2011247621-A1 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010
AU-2011247621-B2 Immunoassay for chromogranin a, antibodies and kit Active 28-Apr-2010
AU-2010236056-A1 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite Active 27-Oct-2009 G01N33/82
To view DIAsource’s complete patent history, request access »

DIAsource Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DIAsource Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DIAsource‘s full profile, request access.

Request a free trial

DIAsource Investments & Acquisitions (2)

DIAsource’s most recent deal was a Corporate Asset Purchase with Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa). The deal was made on 30-Jul-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) 30-Jul-2018 Corporate Asset Purchase Buildings and Property
Viro-Immun Diagnostics 01-Sep-2017 Merger/Acquisition Diagnostic Equipment
To view DIAsource’s complete investments and acquisitions history, request access »

DIAsource FAQs

  • When was DIAsource founded?

    DIAsource was founded in 1996.

  • Where is DIAsource headquartered?

    DIAsource is headquartered in Louvain-la-Neuve, Belgium.

  • What is the size of DIAsource?

    DIAsource has 84 total employees.

  • What industry is DIAsource in?

    DIAsource’s primary industry is Diagnostic Equipment.

  • Is DIAsource a private or public company?

    DIAsource is a Private company.

  • What is the current valuation of DIAsource?

    The current valuation of DIAsource is .

  • What is DIAsource’s current revenue?

    The current revenue for DIAsource is .

  • Who are DIAsource’s investors?

    AnteoTech and Invitrogen have invested in DIAsource.

  • Who are DIAsource’s competitors?

    LEX Diagnostics, ELITechGroup, Hain Lifescience, BioGenex Laboratories, and Nanomix are some of the 29 competitors of DIAsource.

  • When was DIAsource acquired?

    DIAsource was acquired on 04-Sep-2017.

  • Who acquired DIAsource?

    DIAsource was acquired by BioVendor Laboratorni Medicina.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »